News Daily News Lower-Calorie Mediterranean Diet Plus Exercise Boosts Diabetes Prevention Todd Neale August 25, 2025
News Daily News AI Has Great Potential in CV Pharmacotherapy, but Much Work Lies Ahead: Review Todd Neale July 24, 2025
News Daily News Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says Todd Neale June 06, 2025
News Daily News Increased CVD Risk Seen Up to 30 Years Before Type 2 Diabetes Diagnosis Todd Neale November 28, 2024
News Daily News CMS Proposal Would Expand Medicare, Medicaid Coverage for GLP-1 Drugs Todd Neale November 27, 2024
News Daily News Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key Todd Neale November 13, 2024
News Daily News Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows Todd Neale September 25, 2024
News Daily News Semaglutide Has Similar Benefits in Women and Men With HFpEF Todd Neale June 26, 2024
News Daily News EMA: No Evidence of Link Between GLP-1 Receptor Agonists and Suicidal Thoughts Todd Neale April 12, 2024
News Daily News Injectable Semaglutide Shortage Forces Physicians to Pivot Todd Neale February 05, 2024
News Daily News GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks Todd Neale January 21, 2024
News Daily News FDA: No Signs of Link Between GLP-1s and Suicidal Thoughts, Actions Todd Neale January 12, 2024
News Daily News SGLT2i May Be Helpful Early After Acute MI in Diabetic Patients Todd Neale July 17, 2023
News Daily News Checking Cumulative High BP Exposure Hones CV Risk Prediction in Diabetes Todd Neale September 14, 2022
News Daily News Lowering BP Boosts CV Health Irrespective of Diabetes: Meta-analysis Todd Neale August 02, 2022
News Daily News Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results Todd Neale July 06, 2021